A very potent factor V inhibitor interferes with the levels of all coagulation factors and causes a fatal hemorrhagic syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A very potent factor V inhibitor interferes with the levels of all coagulation factors and causes a fatal hemorrhagic syndrome

Published:2019-05-28 Issue:2 Volume:103 Page:137-139
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Hoffmann Claire¹,Amiral Jean²,Rezig Schéhérazade³,Kerspern Hélène⁴,Jantzem Hélène⁵,Robin Sara⁶,Collins Adam¹,Mornet Clelia¹,Mingant Fanny¹,Pan Petesch Brigitte⁷,Ianotto Jean‐Christophe⁷,Lippert Eric¹⁸,Galinat Hubert¹^ORCID

Affiliation:

1. CHRU Brest – Laboratoire d'Hématologie Brest France

2. HYPHEN BioMed Neuville sur Oise France

3. CHRU Brest – Service de Maladies Infectieuses Brest France

4. CHRU BREST – Laboratoire de Biochimie Brest France

5. CHRU BREST – Pharmacovigilance Brest France

6. CHRU Brest – Service de Médecine Interne Brest France

7. CHRU BREST – Service d'Hématologie Clinique Brest France

8. Univ Brest, Inserm, EFS, UMR 1078, GGB Brest France

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13249

Reference5 articles.

1. Development of antibodies to thrombin and factor V with recurrent bleeding in a patient exposed to topical bovine thrombin;Zehnder JL;Blood,1990

2. Acquired factor V inhibitors: a systematic review

3. Massive Blutungsneigung bei zwei Patienten mit Faktor-V-Hemmkörper und Anti-Phospholipid-Antikörpern nach Ciprofloxacin-Einnahme

4. A Circulating Factor V Inhibitor: Possible Side Effect of Treatment with Streptomycin

5. Hemorrhagic death associated with a high titer factor V inhibitor

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Generation and pathogenicity of autoantibodies associated to thrombosis and hemostasis;Exploration of Immunology;2024-02-05

2. Considerations for simultaneous detection of autoantibodies to coagulation factor and lupus anticoagulant;Exploration of Immunology;2023-08-30

3. Autoimmune complications of COVID-19 and potential consequences for long-lasting disease syndromes;Transfusion and Apheresis Science;2023-02

4. Vaccine induced thrombotic thrombocytopenia: development and reactivity of anti-platelet factor 4 antibodies and immune pathogenic mechanisms;Exploration of Immunology;2022-08-31

5. Measurement of coagulation factor antibody levels is useful for diagnosis and determining therapeutic efficacy in hemorrhagic patients with autoantibodies to coagulation factor VIII and factor V: results from a single center in Japan;International Journal of Hematology;2021-09-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3